更多文章
Pfizer’s sickle cell drug gets pulled off the market. Plus, Akeso’s global ambitions, 23andMe needs saving, and more.
6 个月
The CEO behind Summit Therapeutics. Plus, Embedded Bias, China biotech ban, debate takeaways, and much more.
6 个月
STAT's Embedded Bias Investigation. Plus, an exclusive on Novartis, Summit Therapeutics vs. Merck, the next obesity target, and more.
6 个月